Course of cytomegalovirus retinitis in the era of highly active antiretroviral therapy: Five-year outcomes

Ophthalmology

Volumn 117, Issue 11, 2010, Pages

  Jabs, Douglas A ^a,b   Ahuja, Alka ^b   Van Natta, Mark ^b   Lyon, Alice ^c   Srivastava, Sunil ^d   Gangaputra, Sapna ^e  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c NORTHWESTERN UNIVERSITY   (United States)

^d EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; CD4+ T LYMPHOCYTE; CLINICAL EVALUATION; CLINICAL TRIAL; CYTOMEGALOVIRUS RETINITIS; DISEASE COURSE; EYE PHOTOGRAPHY; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; IMMUNOCOMPROMISED PATIENT; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; MORTALITY; MULTICENTER STUDY; OBSERVATIONAL STUDY; OPHTHALMOLOGY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RETINA DETACHMENT; TREATMENT OUTCOME; UVEITIS; VISUAL IMPAIRMENT; ADOLESCENT; AGED; AIDS-RELATED OPPORTUNISTIC INFECTIONS; CD4 LYMPHOCYTE COUNT; FOLLOW UP; IMMUNOLOGY; MIDDLE AGED; PHYSIOLOGY; RETINAL DETACHMENT; UNITED STATES; VISUAL ACUITY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CD4 LYMPHOCYTE COUNT; CD4-POSITIVE T-LYMPHOCYTES; CYTOMEGALOVIRUS RETINITIS; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RETINAL DETACHMENT; TREATMENT OUTCOME; UNITED STATES; UVEITIS; VISUAL ACUITY; YOUNG ADULT;

EID: 78049242404     PISSN: 01616420     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ophtha.2010.03.031     Document Type: Article

References (44)

1. D.A. Jabs Ocular manifestations of HIV infection Trans Am Ophthalmol Soc 93 1995 623 683
2. J.E. Gallant, R.D. Moore, D.D. Richman Zidovudine Epidemiology Study Group Incidence and natural history of cytomegalovirus disease in patients with advanced human immunodeficiency virus disease treated with zidovudine J Infect Dis 166 1992 1223 1227
3. P. Pertel, R. Hirschtick, and J. Phair Risk of developing cytomegalovirus retinitis in persons infected with the human immunodeficiency virus J Acquir Immune Defic Syndr 5 1992 1069 1074
4. D.R. Hoover, Y. Peng, and A. Saah Occurrence of cytomegalovirus retinitis after human immunodeficiency virus immunosuppression Arch Ophthalmol 114 1996 821 827
5. Studies of Ocular Complications of AIDS Research Group, AIDS Clinical Trials Group Foscarnet-Ganciclovir Cytomegalovirus Retinitis Trial 4: visual outcomes Ophthalmology 101 1994 1250 1261
6. J.E. Thorne, D.A. Jabs, J.H. Kempen Studies of Ocular Complications of AIDS Research Group Incidence of and risk factors for visual acuity loss among patients with AIDS and cytomegalovirus retinitis in the era of highly active antiretroviral therapy Ophthalmology 113 2006 1432 1440 (Pubitemid 44108166)
7. J.E. Thorne, D.A. Jabs, J.H. Kempen Studies of Ocular Complications of AIDS Research Group Causes of visual acuity loss among patients with AIDS and cytomegalovirus retinitis in the era of highly active antiretroviral therapy Ophthalmology 113 2006 1441 1445 (Pubitemid 44108167)
8. F.J. Palella Jr, K.M. Delaney, A.C. Moorman HIV Outpatient Study Investigators Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection N Engl J Med 338 1998 853 860
9. C.D. Holtzer, M.A. Jacobson, and W.K. Hadley Decline in the rate of specific opportunistic infections at San Francisco General Hospital, 19941997 AIDS 12 1998 1931 1933
10. M.A. Jacobson, H. Stanley, and C. Holtzer Natural history and outcome of new AIDS-related cytomegalovirus retinitis diagnosed in the era of highly active antiretroviral therapy Clin Infect Dis 30 2000 231 233
11. D.A. Jabs, M.L. Van Natta, J.T. Holbrook Studies of the Ocular Complications of AIDS Research Group Longitudinal Study of the Ocular Complications of AIDS: 1. Ocular diagnoses at enrollment Ophthalmology 114 2007 780 786
12. D.A. Jabs AIDS and ophthalmology, 2008 Arch Ophthalmol 126 2008 1143 1146
13. D.A. Jabs, J.T. Holbrook, M.L. Van Natta Studies of Ocular Complications of AIDS Research Group Risk factors for mortality in patients with AIDS in the era of highly active antiretroviral therapy Ophthalmology 112 2005 771 779
14. D.A. Jabs, G. Bolton, J.P. Dunn, and A.G. Palestine Discontinuing anticytomegalovirus therapy in patients with immune reconstitution after combination antiretroviral therapy Am J Ophthalmol 126 1998 817 822
15. C. Tural, J. Romeu, and G. Sirera Long-lasting remission of cytomegalovirus retinitis without maintenance therapy in human immunodeficiency virus-infected patients J Infect Dis 177 1998 1080 1083
16. J.C. Macdonald, F.J. Torriani, and L.S. Morse Lack of reactivation of cytomegalovirus (CMV) retinitis after stopping CMV maintenance therapy in AIDS patients with sustained elevations in CD4 T cells in response to highly active antiretroviral therapy J Infect Dis 177 1998 1182 1187
17. S.M. Whitcup, E. Fortin, and A.S. Lindblad Discontinuation of anticytomegalovirus therapy in patients with HIV infection and cytomegalovirus retinitis JAMA 282 1999 1633 1637
18. O. Kirk, P. Reiss, and C. Uberti-Foppa Safe interruption of maintenance therapy against previous infection with four common HIV-associated opportunistic pathogens during potent antiretroviral therapy Ann Intern Med 137 2002 239 250
19. J.E. Kaplan, C. Benson, and K.K. Holmes Guidelines for prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America MMWR Recomm Rep 58 2009 1 198
20. F.J. Torriani, W.R. Freeman, and J.C. Macdonald CMV retinitis recurs after stopping treatment in virological and immunological failure of potent antiretroviral therapy AIDS 14 2000 173 180
21. S.C. Johnson, C.A. Benson, D.W. Johnson, and A. Weinberg Recurrences of cytomegalovirus retinitis in a human immunodeficiency virus-infected patient despite potent antiretroviral therapy and apparent immune reconstitution Clin Infect Dis 32 2001 815 819
22. K.V. Komanduri, J. Feinberg, and R.K. Hutchins Loss of cytomegalovirus-specific CD4+ T cell responses in human immunodeficiency virus type 1-infected patients with high CD4+ T cell counts and recurrent retinitis J Infect Dis 183 2001 1285 1289
23. D.A. Jabs, M.L. Van Natta, J.E. Thorne Studies of Ocular Complications of AIDS Research Group Course of cytomegalovirus retinitis in the era of highly active antiretroviral therapy: 1. Retinitis progression Ophthalmology 111 2004 2224 2231 (Pubitemid 39585188)
24. D.A. Jabs, M.L. Van Natta, J.E. Thorne Studies of Ocular Complications of AIDS Research Group Course of cytomegalovirus retinitis in the era of highly active antiretroviral therapy: 2. Second eye involvement and retinal detachment Ophthalmology 111 2004 2232 2239 (Pubitemid 39575593)
25. E.L. Murphy, A.C. Collier, L.A. Kalish Viral Activation Transfusion Study Investigators Highly active antiretroviral therapy decreases mortality and morbidity in patients with advanced HIV disease Ann Intern Med 135 2001 17 26
26. D.A. Jabs, M.L. Van Natta, J.T. Holbrook Studies of the Ocular Complications of AIDS Research Group Longitudinal Study of the Ocular Complications of AIDS: 2. Ocular examination results at enrollment Ophthalmology 114 2007 787 793 (Pubitemid 46483694)
27. K.G. Castro, J.W. Ward, and L. Slutsker 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults MMWR Recomm Rep 41 RR-17 1992 1 19
28. Studies of Ocular Complications of AIDS (SOCA) Research Group, AIDS Clinical Trials Group (ACTG) Studies of Ocular Complications of AIDS Foscarnet-Ganciclovir Cytomegalovirus Retinitis Trial: 1. Rationale, design and methods Control Clin Trials 13 1992 22 39
29. F.L. Ferris III, A. Kassof, G.H. Bresnick, and I. Bailey New visual acuity charts for clinical research Am J Ophthalmol 94 1982 91 96
30. Q.D. Nguyen, J.H. Kempen, and S.G. Bolton Immune recovery uveitis in patients with AIDS and cytomegalovirus retinitis after highly active antiretroviral therapy Am J Ophthalmol 129 2000 634 639
31. M.R. Robinson, G. Reed, and K.G. Csaky Immune-recovery uveitis in patients with cytomegalovirus retinitis taking highly active antiretroviral therapy Am J Ophthalmol 130 2000 49 56
32. M.P. Karavellas, D.J. Plummer, and J.C. MacDonald Incidence of immune recovery vitritis in cytomegalovirus retinitis patients following institution of successful highly active antiretroviral therapy J Infect Dis 179 1999 697 700
33. J.H. Kempen, Y.I. Min, W.R. Freeman Studies of Ocular Complications of AIDS Research Group Risk of immune recovery uveitis in patients with AIDS and cytomegalovirus retinitis Ophthalmology 113 2006 684 694
34. D.G. Altman Practical Statistics for Medical Research London: Chapman and Hall 1991 213 215 24156
35. E.L. Kaplan, and P. Meier Nonparametric estimation from incomplete observations J Am Stat Assoc 53 1958 457 481
36. P.M. Tarwater, J. Mellors, and M.E. Gore Methods to assess population effectiveness of therapies in human immunodeficiency virus incident and prevalent cohorts Am J Epidemiol 154 2001 675 681
37. D.Y. Lin Cox regression analysis of multivariate failure time data: the marginal approach Stat Med 13 1994 2233 2247
38. K.Y. Liang, and S.L. Zeger Longitudinal data analysis using generalized linear models Biometrika 73 1986 13 22
39. D.A. Jabs, M.L. Van Natta, and J.H. Kempen Characteristics of patients with cytomegalovirus retinitis in the era of highly active antiretroviral therapy Am J Ophthalmol 133 2002 48 61
40. G.N. Holland, J.D. Vaudaux, S.M. Jeng CMV Retinitis Study Group Characteristics of untreated AIDS-related cytomegalovirus retinitis I. Findings before the era of highly active antiretroviral therapy (1988 to 1994) Am J Ophthalmol 145 2008 5 11
41. G.N. Holland, J.D. Vaudaux, K.M. Shiramizu Southern California HIV/Eye Consortium Characteristics of untreated AIDS-related cytomegalovirus retinitis II. Findings in era of highly active antiretroviral therapy (1997 to 2000) Am J Ophthalmol 145 2008 12 22
42. Centers for Disease Control and Prevention (CDC) Late HIV testing34 states, 1996-2005 MMWR Morb Mortal Wkly Rep 58 2009 661 665
43. D. Mitry, D.G. Charteris, and B.W. Fleck The epidemiology of rhegmatogenous retinal detachment: geographic variation and clinical associations Br J Ophthalmol 94 2010 678 684
44. R.B. Nussenblatt, and H.C. Lane Human immunodeficiency virus disease: changing patterns of intraocular inflammation Am J Ophthalmol 125 1998 374 382